Compare TECH & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | DLB |
|---|---|---|
| Founded | 1976 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 6.4B |
| IPO Year | 1989 | 2005 |
| Metric | TECH | DLB |
|---|---|---|
| Price | $59.83 | $63.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 5 |
| Target Price | $71.23 | ★ $93.60 |
| AVG Volume (30 Days) | ★ 1.6M | 591.2K |
| Earning Date | 02-04-2026 | 01-28-2026 |
| Dividend Yield | 0.54% | ★ 2.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.49 | ★ 2.62 |
| Revenue | $1,216,732,000.00 | ★ $1,349,130,000.00 |
| Revenue This Year | $2.33 | $5.03 |
| Revenue Next Year | $7.05 | $4.02 |
| P/E Ratio | $120.82 | ★ $24.51 |
| Revenue Growth | 3.85 | ★ 5.92 |
| 52 Week Low | $46.01 | $64.02 |
| 52 Week High | $79.28 | $89.66 |
| Indicator | TECH | DLB |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 29.74 |
| Support Level | $58.54 | $65.96 |
| Resistance Level | $59.64 | $66.34 |
| Average True Range (ATR) | 1.46 | 1.00 |
| MACD | 0.11 | -0.32 |
| Stochastic Oscillator | 80.40 | 0.41 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.